Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome - Oddo,S.; Billings,L.; Kesslak,J.P.; Cribbs,D.H.; LaFerla,F.M. (Neuron, 2004)